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Catecholamine cardiotoxicity is known for a long time, but its patho-
genesis is still incompletely understood. Although traditionally attributed to 
excessive β-adrenergic stimulation, there is a hypothesis that the catecholamine-
induced cardiac cell damage includes involvement of oxidation products of 
catecholamines, which may arise due to spontaneous oxidation of catechola-
mines under aerobic conditions. Spontaneous oxidation of catecholamines is a 
sequence of redox reactions leading to the formation of numerous reactive in-
termediates, such as o-semiquinones and o-quinones, including aminochromes 
that are subject to redox cyclization generating reactive oxygen species (ROS). 
The generated ROS and aminochromes are toxic for cells. In addition, the 
autooxidation may be catalyzed by transition metals, which suggests that free 
intracellular iron (Fe) ions – the most abundant transition metal in the body – 
can promote not only the Haber-Weiss reaction of ROS, but also catalyze the 
conversion of catecholamines to aminochromes and aggravate the damage to 
heart cells. Fe chelation may therefore offer the possibility of cardioprotection 
of cardiac cells against catecholamine cardiotoxicity. 
This work was aimed to create appropriate experimental models to study 
complex features of catecholamines. We evaluated spontaneous oxidation of 
catecholamines in buffered solution by spectrophotometry measurements and 
HPLC analysis, formation of hydrogen peroxide, redox activity and oxidative 
effects of parent and oxidized catecholamines and their complexes with Fe by 
determination of oxidized ascorbate, ROS production in the rat cardiomyoblast 
cell line H9c2 by determination of dichlorofluorescein, toxicity of catechola-
mines and their oxidation products to H9c2 cells by vital staining with neutral 
red and by microscopy with fluorescence nuclei staining and finally the ability 
of catecholamines to affect apoptosis by caspase activity determination. Using 
these models, the objective was to study the role of free Fe ions in pathobio-
chemistry of catecholamine cardiotoxicity and to evaluate the possibility of its 
protection by Fe chelation. Protective potential of different chelators was 
evaluated – not only of experimental agents, but also of drugs introduced into 
clinical practice. 
Results of our in vitro experiments support the assumption that oxidative 
damage plays a significant role in the process of catecholamine-induced cardio-
toxicity. Spontaneous decrease in the concentration of catecholamines (adrena-
line and isoprenaline) was started in buffered solution during the 24 h incuba-
tion together with a gradual oxidation of catecholamines to unspecified oxida-
tion products. This oxidation was significantly aggravated by the presence of Fe 
ions, which may form complexes with catecholamines and their oxidation 
products. Complexes of Fe with the oxidized catecholamines had a pronounced 
redox activity towards ascorbate. Experiments with cardiomyoblasts cell line 
H9c2 revealed higher toxicity of oxidation products than of the parent cate-
cholamines and confirmed the formation intracellular ROS in H9c2 cells after 
their exposure to oxidized catecholamines. 
Chelation of Fe significantly reduced the spontaneous oxidation of cate-
cholamines and the formation of oxidation products in solution, as well as the 
redox activities of their complexes with Fe. Fe chelation was also able to pro-
vide significant protection of cardiac H9c2 cells, preserve their viability and 
suppress the formation of ROS inside the cells. Small lipophilic chelators of Fe, 
which are able to penetrate into cells in sufficiently effective concentrations 
such as experimental salicylaldehyde isonicotinoyl hydrazone (SIH) and clini-
cally used deferiprone (L1) and deferasirox (ICL670A), have shown consider-
able protective potential. Furthermore prochelator boronic ester of SIH (BSIH) 
was shown as very promising, as it was minimally toxic in comparison to the 
classic chelators. 
Hence our results confirm that the catecholamines are able to undergo 
Fe-promoted oxidation, which gives rise to unstable and toxic oxidation prod-
ucts, and redox cycling that cause production of free radicals. The resulting 
oxidation products are together with the ROS responsible for the cardiotoxicity 
of catecholamines and necrotic cell death. Free Fe ions are significantly involved 
in all redox reactions leading to formation of ROS and oxidation of catechola-
mines. 
Chelation of Fe proved to be a suitable tool of cardioprotection, which 
has considerable potential to protect heart cells against catecholamine cardio-
toxicity by the inhibition of conversion of catecholamines, thus protecting car-
diac cells against damage mediated by ROS. 
 
